Related Experiment Videos
Cardiac pacing in the long QT syndrome: review of available data and practical recommendations
1Department of Cardiology, Sourasky-Tel Aviv Medical Center, and Sackler-School of Medicine, Tel Aviv University, Israel. viskin_s@netvision.net.il
Insights
Cardiac pacing may prevent arrhythmic death in Long QT Syndrome (LQTS) patients, especially those with LQT3 or pause-dependent arrhythmias. Careful pacemaker programming is crucial to avoid pauses and optimize patient selection for this intervention.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Long QT Syndrome (LQTS) is a condition associated with increased risk of life-threatening arrhythmias.
- Cardiac pacing is a potential therapeutic strategy for managing LQTS.
- Optimization of pacing strategies is needed to improve outcomes and prevent sudden cardiac death in LQTS patients.
Purpose of the Study:
- To review existing data on cardiac pacing in Long QT Syndrome (LQTS).
- To identify patient selection criteria and pacemaker programming parameters that may prevent arrhythmic death.
- To evaluate the potential benefits of pacing across different LQTS genotypes.
Main Methods:
- Systematic review of published literature on cardiac pacing in LQTS.
- Analysis of patient data focusing on genotype, pacing parameters, and arrhythmic events.
- Evaluation of the impact of bradycardia and pauses on repolarization in LQTS.
Main Results:
- LQT3 genotype patients may particularly benefit from pacing due to worsened repolarization dispersion during bradycardia.
- Pacing may be beneficial for LQTS patients experiencing pause-dependent arrhythmias.
- Premature to exclude benefits of pacing in other LQTS genotypes.
Conclusions:
- Optimized patient selection and pacemaker programming, including a fast lower rate limit and disabling pause-inducing features, can help prevent arrhythmic death in LQTS.
- Pause-prevention pacing algorithms show promise for this patient population.
- Further research is warranted to fully elucidate the role of pacing in all LQTS genotypes.
Abstract:
A review of published data on cardiac pacing in the long QT syndrome (LQTS) is presented, in the hope that optimization of patient selection and pacemaker programming will prevent arrhythmic death. LQT3 patients may derive particular benefit from pacing because the dispersion of repolarization worsens steeply during bradycardia in this genotype. However, concluding that other genotypes will not benefit from pacing is premature. Pacing may be especially beneficial for patients with "pause-dependent" arrhythmias. Programming should include a sufficiently fast lower rate limit. Features that allow heart rate slowing beyond the lower rate limit or that may trigger pauses must be programmed "off" because pauses are proarrhythmic in this population. Pause-prevention pacing algorithms may be beneficial.